FANTACUZZI, MARIALUIGIA
 Distribuzione geografica
Continente #
NA - Nord America 5.840
EU - Europa 3.526
AS - Asia 3.268
Continente sconosciuto - Info sul continente non disponibili 585
SA - Sud America 346
AF - Africa 59
OC - Oceania 2
Totale 13.626
Nazione #
US - Stati Uniti d'America 5.595
SG - Singapore 1.226
IT - Italia 910
CN - Cina 883
IE - Irlanda 414
TR - Turchia 385
UA - Ucraina 352
SE - Svezia 349
RU - Federazione Russa 321
VN - Vietnam 296
BR - Brasile 282
GB - Regno Unito 267
FR - Francia 261
IN - India 235
DE - Germania 201
CA - Canada 132
PL - Polonia 126
FI - Finlandia 104
HK - Hong Kong 49
ES - Italia 44
BD - Bangladesh 40
AT - Austria 34
MX - Messico 30
NL - Olanda 30
JP - Giappone 28
LT - Lituania 26
CZ - Repubblica Ceca 24
ZA - Sudafrica 22
BE - Belgio 21
ID - Indonesia 17
AR - Argentina 14
PK - Pakistan 14
PT - Portogallo 14
VE - Venezuela 14
CR - Costa Rica 12
PH - Filippine 12
TT - Trinidad e Tobago 12
HN - Honduras 11
JM - Giamaica 11
CW - ???statistics.table.value.countryCode.CW??? 10
GT - Guatemala 10
IQ - Iraq 10
KR - Corea 10
EC - Ecuador 9
CL - Cile 8
CO - Colombia 8
IL - Israele 8
MY - Malesia 8
SA - Arabia Saudita 8
NI - Nicaragua 7
EG - Egitto 6
MA - Marocco 6
TW - Taiwan 6
CH - Svizzera 5
DZ - Algeria 5
EE - Estonia 5
GR - Grecia 5
HR - Croazia 5
KE - Kenya 5
PR - Porto Rico 5
AE - Emirati Arabi Uniti 4
ET - Etiopia 4
IR - Iran 4
PE - Perù 4
SV - El Salvador 4
AL - Albania 3
CI - Costa d'Avorio 3
JO - Giordania 3
PY - Paraguay 3
UY - Uruguay 3
YE - Yemen 3
AU - Australia 2
BB - Barbados 2
BH - Bahrain 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GP - Guadalupe 2
KZ - Kazakistan 2
LB - Libano 2
NP - Nepal 2
SC - Seychelles 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AW - Aruba 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BM - Bermuda 1
BZ - Belize 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GY - Guiana 1
KH - Cambogia 1
KW - Kuwait 1
MM - Myanmar 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
Totale 13.047
Città #
Singapore 915
San Jose 655
Chandler 501
Ashburn 435
Jacksonville 430
Dublin 407
Dallas 262
Izmir 244
Beijing 227
Dearborn 210
Chieti 209
Princeton 169
Council Bluffs 167
Southend 148
Los Angeles 130
Santa Clara 129
Nanjing 128
The Dalles 117
Ho Chi Minh City 101
Kraków 89
New York 83
Cambridge 82
Ann Arbor 79
Wilmington 69
Nanchang 63
Hanoi 60
Washington 56
Munich 55
Altamura 49
Tongling 48
Buffalo 43
Hong Kong 43
Moscow 42
North Bergen 42
Pescara 38
Rome 37
São Paulo 35
Warsaw 35
Atlanta 34
Boardman 34
Hebei 31
Orem 31
Bosa 30
Milan 30
Shenyang 30
Teramo 30
Brooklyn 29
Denver 28
Phoenix 28
Helsinki 27
Redondo Beach 27
Da Nang 25
Jiaxing 25
Toronto 25
Brno 23
Columbus 23
Houston 23
Jinan 23
Montreal 23
Vienna 23
Chennai 22
Chicago 22
Kunming 22
Stockholm 22
Brussels 21
London 20
Ottawa 20
Tianjin 20
Tokyo 20
Changsha 19
Kocaeli 17
Hefei 16
Amsterdam 15
Johannesburg 15
Poplar 15
Haiphong 14
Mount Pleasant 14
San Francisco 14
Turku 14
Manchester 13
Woodbridge 13
Hangzhou 12
Mexico City 12
Naples 12
Bologna 11
Nuremberg 11
Ankara 10
Falls Church 10
Kingston 10
League City 10
Norwalk 10
Vilnius 10
Willemstad 10
Augusta 9
Biên Hòa 9
Frankfurt am Main 9
Ningbo 9
San José 9
Seattle 9
Vancouver 9
Totale 7.793
Nome #
Anticancer Activity of Stilbene-Based Derivatives 208
Synthesis and antibacterial evaluation of oxazolidin-2-ones structurally related to linezolid 205
Synthesis of 2-aryloxypropanoic acids analogues of clofibric acid and assignment of the absolute configuration by 1H NMR spectroscopy and DFT calculations 204
Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-L-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma 198
Titanium-Promoted Acylation of Sulfonamides to N-Acylsulfonamide PPAR Antagonists 189
Novel Phenyldiazenyl Fibrate Analogues as PPAR α/γ/δ Pan-Agonists for the Amelioration of Metabolic Syndrome 188
Recent developments of amidine-like compounds as selective NOS inhibitors 185
Synthesis, biological activity, and docking studies of novel acetamidines as selective modulators of nitric oxide synthase 184
Valutazione biologica dei derivati dell'acido clofibrico come potenziali ligandi PPARs 183
Synthesis and structure-activity relationships of fibrate-based analogues inside PPARs 183
Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation 180
Asymmetric Synthesis of Arylpropionic Acids and Aryloxy Acids by Using Lactamides as Chiral Auxiliaries 178
Synthesis and Biological Evaluation of 2-Heteroarylthioalkanoic Acid Analogues of Clofibric Acid as Peroxisome Proliferator-Activated Receptor alfa Agonists 177
Cytotoxic effect of a family of Peroxisome Proliferator-Activated Receptor antagonists in colorectal and pancreatic cancer cell lines 175
Discovery of new FXR agonists based on 6-ECDCA binding properties by virtual screening and molecular docking 173
Benzothiazole-based N-(phenylsulfonyl)amides as a novel familyof PPARa antagonists 170
Synthesis and biological evaluation of potential Nitric Oxide Synthase inhibitors 169
The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In Vitro 168
Druggability profile of stilbene-derived PPAR agonists: Determination of physicochemical properties and PAMPA study 167
Candida rugosa lipase-catalysed kinetic resolution of 2-substituted-aryloxyacetic esters with dimethylsulfoxide and isopropanol as additives 165
Enantiomeric separation of Gemfibrozil chiral analogues by capillary electrophoresis with heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin as chiral selector 162
PPARα agonists based on stilbene and its bioisosteres: Biological evaluation and docking studies 162
Synthesis and biological evaluation of gemfibrozil chiral analogs as potential PPARa agonists 159
Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors 156
Synthesis and cytotoxic effects on pancreatic cancer cells of resveratrol analogs 155
Syntesis and pharmacological evaluation of fibrates analogues as cardiovascular agents 154
Fibrate-derived N-(methylsulfonyl)amides with antagonistic properties on PPARa 154
Enantiomeric separation of some demethylated analogues of clofibric acid by capillary zone electrophoresis and nano-liquid chromatography 153
Indazole, Pyrazole, and Oxazole Derivatives Targeting Nitric Oxide Synthases and Carbonic Anhydrases 153
Sulfonimide and Amide Derivatives as Novel PPARα Antagonists: Synthesis, Antiproliferative Activity, and Docking Studies 152
Sintesi e valutazione biologica di analoghi eterociclici del gemfibrozil a potenziale attività cardiovascolare 150
Amidine-Based Bioactive Compounds for the Regulation of Arginine Metabolism 149
Selective Acetamidine-Based Nitric Oxide Synthase Inhibitors: Synthesis, Docking, and Biological Studies 148
Amidine-Based Compounds Affecting L-Arginine Metabolism 148
Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure-Activity Relationship Studies and Target Prediction Analysis 146
Selective inhibition of inducible Nitric Oxide Synthase by derivatives of acetamidine 146
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 145
Fibrate-based N-acylsulphonamides targeting carbonic anhydrases: synthesis, biochemical evaluation, and docking studies 145
Structural development studies of PPARs ligands based on tyrosine scaffold 145
Novel aminobenzyl-acetamidine derivative modulate the differential regulation of NOSs in LPS induced inflammatory response: Role of PI3K/Akt pathway 144
Time factor in antiretroviral adherence: analysis of adherence to single-tablet regimens versus multiple-tablet regimens over a 5-year period 143
Synthesis of naphthyl-, quinolin- and anthracenyl analogues of clofibric acid as PPARα agonists 143
N-Substituted acetamidines and 2-methylimidazole derivatives as selective inhibitors of neuronal nitric oxide synthase 140
Discovery of gemfibrozil analogues that activate PPARa and enhance the expression of gene CPT1A involved in fatty acids catabolism 140
Synthesis and biological evaluation of new acetamidines as selective inhibitors of Nitric Oxide Synthases 139
Analoghi eterociclici dell’acido clofibrico: sintesi, attività antiaggregante piastrinica e separazione in elettroforesi capillare 136
Azo derivatives of monoterpenes as anti-Helicobacter pylori agents: from synthesis to structure-based target investigation 135
Starting a new series of acetamidines as Nitric Oxide Sinthase inhibitors 135
Coumarin-Based Dual Inhibitors of Human Carbonic Anhydrases and Monoamine Oxidases Featuring Amino Acyl and (Pseudo)-Dipeptidyl Appendages: In Vitro and Computational Studies 134
Synthesis and biological evaluation of novel acetamidines as nitric oxide inhibitors 132
Selective Inhibition of iNOS by Benzyl- and Dibenzyl Derivatives of N-(3-Aminobenzyl)acetamidine. 132
Dual-PPAR agonists based on stilbene scaffold: synthesis and biological evaluation 131
Platelet aggregation: synthesis and pharmacological evaluation of clofibric acid analogues 129
Effect of stilbene and chalcone scaffolds incorporation in clofibric acid on PPARα agonistic activity 129
Design, synthesis and biological evaluation of aromatase inhibitors based on sulfonates and sulfonamides of resveratrol 129
Sintesi di esteri del gemfibrozil donatori di ossido nitrico 128
null 128
Enantioseparazione di analoghi chirali dei fibrati in Elettroforesi Capillare e nano-Cromatografia Liquida 127
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential 127
Synthesis and cytotoxicity evaluation of novel amide and sulfonimide PPARa antagonists 126
Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors 125
Selective inhibition of iNOS by benzyl- and dibenzyl derivatives of N-(3-aminobenzyl)acetamidine on cellular line H2C9 124
Methods to Evaluate the Activity of Nitric Oxide Synthase 123
Synthesis of novel benzothiazole amides: Evaluation of PPAR activity and anti-proliferative effects in paraganglioma, pancreatic and colorectal cancer cell lines 122
Novel Phenyldiazenyl Fibrate Analogues as PPAR Agonists: Design, Synthesis and Pharmacological Evaluation 121
Design, synthesis and biological evaluation of imidazole and triazole-based carbamates as novel aromatase inhibitors 121
A novel life for antitumor combretastatins: Recent developments of hybrids, prodrugs, combination therapies, and antibody-drug conjugates 120
In vitro protective effects of resveratrol and stilbene alkanoic derivatives on induced oxidative stress on c2c12 and mcf7 cells 120
Synthesis, structure-activity relationships and molecular docking studies of phenyldiazenyl sulfonamides as aromatase inhibitors 120
Synthesis and pharmacological evaluation of gemfibrozil chiral analogues as cardiovascular agents 117
Antiviral Peptides as Anti-Influenza Agents 117
Capillary electrophoretic enantioseparation of gemfibrozil analogues by use of TM-b-cyclodextrin as chiral selector 114
Sintesi di derivati eterociclici dell’acido clofibrico a potenziale attività antiaggregante piastrinica 114
Fibrate-Based Analogues as PPARs Agonists: Synthesis and Structure–Activity Relationships 114
Design, synthesis and biological evaluation of novel acetamidines as selective inducible nitric oxide synthase inhibitors 113
Reversed-phase high-performance liquid chromatography method with fluorescence detection to screen nitric oxide synthases inhibitors. 111
QSAR, QSPR and QSRR in terms of 3-D-MoRSE descriptors for in silico screening of clofibric acid analogues 110
Separazione enantiomerica di analoghi chirali dell'acido clofibrico mediante elettroforesi capillare 110
PPAR Ligands Containing Stilbene Scaffold 110
In vitro evaluation of a new selective iNOS inhibitor on normal rat astrocytes and C6 rat glioma cells 108
Pegylation approach applied to erlotinib–carbonic anhydrase inhibitors hybrids towards anticancer agents 103
Screening of NOS activity and selectivity of newly synthesized acetamidines using RP-HPLC 103
PPAR Ligands Induce Antiviral Effects Targeting Perturbed Lipid Metabolism during SARS-CoV-2, HCV, and HCMV Infection 101
Synthetic Approach to Phenylalanine-Proline, and Tyrosine-Proline Hybrid Amino Acids 99
Resveratrol Analogues as Dual Inhibitors of Monoamine Oxidase B and Carbonic Anhydrase VII: A New Multi-Target Combination for Neurodegenerative Diseases? 98
Synthesis, in vitro evaluation, and molecular modelling investigation of benzenesulfonimide Peroxisome Proliferator-Activated Receptors α antagonists 98
Geometric Isomerism of an Acetamidino Derivative Determined by NMR Investigations 97
Benzenesulfonamide derivatives as Vibrio cholerae carbonic anhydrases inhibitors: a computational-aided insight in the structural rigidity-activity relationships 96
Enantiomeric separation of some chiral analogues of clofibric acid by capillary zone electrophoresis and nano-liquid chromatography 96
Sintesi, relazioni struttura-attività e docking di nuovi inibitori delle Ossido Nitrico Sintasi 96
N-Acylsulfonylamides as a new class of PPARa antagonists 96
Development of CDK4/6 Inhibitors: A Five Years Update 93
Protein-protein interactions at a glance: Protocols for the visualization of biomolecular interactions 93
HDAC Inhibitors for the Therapy of Triple Negative Breast Cancer 91
Novel Synthetic Strategies for the Development of Tryptophan-Proline Chimeras, Useful Tool for Drug Discovery 90
A Comprehensive Computational Insight into the PD-L1 Binding to PD-1 and Small Molecules 84
Inhibition of Human Coronavirus 229E by Lactoferrin-Derived Peptidomimetics 83
Erlotinib-containing benzenesulfonamides as anti-Helicobacter pylori agents through carbonic anhydrase inhibition 78
New azolyl-derivatives as multitargeting agents against breast cancer and fungal infections: synthesis, biological evaluation and docking study 74
Resveratrol-based compounds and neurodegeneration: Recent insight in multitarget therapy 66
Totale 13.507
Categoria #
all - tutte 52.133
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.133


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022471 0 0 0 0 54 22 23 52 97 20 70 133
2022/20231.441 103 202 108 136 133 305 71 110 178 17 52 26
2023/2024693 51 21 61 14 43 216 166 10 4 30 9 68
2024/20251.645 73 303 268 21 38 90 64 96 161 73 237 221
2025/20264.036 309 129 444 514 478 218 709 270 396 316 192 61
2026/20271.250 112 180 230 513 215 0 0 0 0 0 0 0
Totale 13.626